SCHEMBL3747547

SCHEMBL3747547

Cc1cc(-c2ccc(C=O)c(Oc3ccccc3Cl)n2)ccc1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
ALDH1A1 P00352 4/20 0.40
KDM4E B2RXH2 2/20 0.40
HPGD P15428 2/20 0.40
CHEK2 O96017 1/20 0.37
CTSA P10619 1/20 0.35
SCN9A Q15858 1/20 0.35
LMNA P02545 1/20 0.34
ADRB2 P07550 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
PTGS2 P35354 1/20 0.34
MAPT P10636 2/20 0.34
HTT P42858 2/20 0.34
NPC1 O15118 2/20 0.34
CASP3 P42574 2/20 0.34
RAB9A P51151 2/20 0.34
SENP8 Q96LD8 2/20 0.34
SENP7 Q9BQF6 2/20 0.34
SENP6 Q9GZR1 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3752590 0.91 KMO (0.38) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL8218294 0.82 LMNA (0.46) KMT2AALDH1A1KDM4EHPGDLMNA
SCHEMBL3759839 0.81 HPGDS (0.42) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL3753774 0.81 RORB (0.40) KMT2ACHEK2CYP1A2
SCHEMBL3750086 0.80 KMT2A (0.44) KMT2AHPGDSCN9ALMNAADRB2
SCHEMBL3752842 0.79 ALDH1A1 (0.40) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL3745406 0.79 KDM1A (0.42) KMT2AKDM4EHPGDLMNAMAPT
SCHEMBL3752115 0.78 CYP1A2 (0.44) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL3753486 0.78 XDH (0.41) ALDH1A1KDM4EHPGDSCN9AMAPT
SCHEMBL3749589 0.77 PDCD1LG2 (0.35) ALDH1A1CTSALMNAHTTERN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100298221-A1 2-PHENOXY NICOTINE ACID DERIVATIVE AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-11-25 US disclosed
US-20100298221-A1 2-PHENOXY NICOTINE ACID DERIVATIVE AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-11-25 US disclosed
US-20100298221-A1 2-PHENOXY NICOTINE ACID DERIVATIVE AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298221-A1 2-PHENOXY NICOTINE ACID DERIVATIVE AND USE THEREOF NAPRT, PNPO, FABP3 MEN1 4297/4885KMT2A 1678/4885ALDH1A1 1855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.